ARTICLE | Company News
Genmab, Roche deal
April 14, 2014 7:00 AM UTC
Roche's Ventana Medical Systems Inc. unit partnered with Genmab to develop an immunohistochemistry (IHC) companion diagnostic for Genmab's HuMax-TF-ADC. The antibody-drug conjugate (ADC) against tissue factor is in a Phase I trial to treat solid tumors. Ventana said financials details are not disclosed. ...